Abstract
Identifying the optimal candidates for concomitant androgen-deprivation therapy among patients receiving metastasis-directed therapy for positive 68Ga-PSMA PET/CT for biochemical recurrent prostate cancer after radical prostatectomy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have